(Q37765627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

0 references

0 references

1 reference

Mark J Simone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Zaldy S Tan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

1 reference

11 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

506-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory mediators in the elderly

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Systemic inflammation and disease progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Delirium in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Clarifying confusion: the confusion assessment method. A new method for detection of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Cytokines and cognition--the case for a head-to-toe inflammatory paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Activation of vascular endothelial cells and perivascular cells by systemic inflammation-an immunohistochemical study of postmortem human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

21 January 2018

Delirium in older people

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Age and neuroinflammation: a lifetime of psychoneuroimmune consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Chemokines are associated with delirium after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Serum biomarkers for delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Cerebral perfusion in sepsis-associated delirium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Cytokines and C-reactive protein production in hip-fracture-operated elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Cytokines and acute phase response in delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Time-course of cytokines during delirium in elderly patients with hip fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Postoperative interleukin-6 and cortisol concentrations in elderly patients with postoperative confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Plasma insulin growth factor-1 and incident delirium in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Inflammation and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Polymorphisms in inflammatory genes and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Association of interleukin-I beta and receptor antagonist gene polymorphisms with late onset Alzheimer's disease in Taiwan Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Inflammation and white matter damage in vascular cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Circulating cytokines in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Inflammatory markers and cognition in well-functioning African-American and white elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

High-sensitivity C-reactive protein and cognitive function in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

The role of microglia and macrophages in the pathophysiology of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Inflammatory markers and the risk of Alzheimer disease: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2010.00173.X

Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression.

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans

1 reference

12 December 2020

beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

1 reference

12 December 2020

Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma

1 reference

12 December 2020

Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway

1 reference

12 December 2020

Increase of plasma IL-6 concentration with age in healthy subjects

1 reference

12 December 2020

Inflammation and neurodegenerative diseases

1 reference

12 December 2020

C-reactive protein levels predict the incidence of delirium and recovery from it

1 reference

12 December 2020

Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin

1 reference

12 December 2020

Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients

1 reference

12 December 2020

Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study.

1 reference

12 December 2020

Psychiatric complications of long-term interferon alfa therapy

1 reference

12 December 2020

Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretion

1 reference

12 December 2020

Elevated circulating levels of IL-6 in schizophrenia

1 reference

12 December 2020

Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.

1 reference

12 December 2020

Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha

1 reference

12 December 2020

Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes

1 reference

12 December 2020

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

12 December 2020

10.1111/J.1755-5949.2010.00173.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

release_qje4usow2fdbfpnhcbam5myucy

5 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qje4usow2fdbfpnhcbam5myucy

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553303%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

20553303

1 reference